tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CANF Stock Latest News

Can-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
Company AnnouncementsCan-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
6d ago
6K
CANF
Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum
PremiumCompany Announcements
Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum
13d ago
6K
CANF
Can-Fite BioPharma to Present Pancreatic Cancer Study Progress at BIO 2025
PremiumCompany Announcements
Can-Fite BioPharma to Present Pancreatic Cancer Study Progress at BIO 2025
20d ago
6K
CANF
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
PremiumThe Fly
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
20d ago
CANF
Can-Fite BioPharma Announces June 2025 Shareholder Meeting
PremiumCompany Announcements
Can-Fite BioPharma Announces June 2025 Shareholder Meeting
2M ago
6K
CANF
Can-Fite BioPharma Secures $175 Million for Phase III Trials
PremiumCompany AnnouncementsCan-Fite BioPharma Secures $175 Million for Phase III Trials
2M ago
6K
CANF
Can-Fite raises $175M to date for namodenoson, piclidenoson development
Premium
The Fly
Can-Fite raises $175M to date for namodenoson, piclidenoson development
2M ago
CANF
Can-Fite BioPharma Gains FDA Compassionate Use Approval for Namodenoson
Premium
Company Announcements
Can-Fite BioPharma Gains FDA Compassionate Use Approval for Namodenoson
3M ago
6K
CANF
Can-Fite BioPharma says medical centers seek authorization for namodenoson
PremiumThe Fly
Can-Fite BioPharma says medical centers seek authorization for namodenoson
3M ago
CANF
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
PTN
ARTL
Can-Fite BioPharma Announces $3 Million Direct Offering
PremiumCompany Announcements
Can-Fite BioPharma Announces $3 Million Direct Offering
3M ago
6K
CANF
Can-Fite price target lowered to $4.50 from $12 at Alliance Global Partners
PremiumThe Fly
Can-Fite price target lowered to $4.50 from $12 at Alliance Global Partners
3M ago
CANF
Can-Fite BioPharma Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsCan-Fite BioPharma Reports 2024 Financial Results and Clinical Progress
3M ago
CANF
Can-Fite BioPharma Secures $3 Million in Direct Offering
Premium
Company Announcements
Can-Fite BioPharma Secures $3 Million in Direct Offering
3M ago
6K
CANF
Can-Fite BioPharma trading resumes
Premium
The Fly
Can-Fite BioPharma trading resumes
3M ago
CANF
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
PremiumThe Fly
Can-Fite BioPharma announces $3.0M registered direct offering of ADSs
3M ago
CANF
Can-Fite BioPharma trading halted, news pending
PremiumThe Fly
Can-Fite BioPharma trading halted, news pending
3M ago
CANF
Can-Fite Projects $685M Revenue from Partnerships
PremiumCompany Announcements
Can-Fite Projects $685M Revenue from Partnerships
3M ago
6K
CANF
Can-Fite BioPharma announces completion of analysis of current partnerships
PremiumThe Fly
Can-Fite BioPharma announces completion of analysis of current partnerships
3M ago
CANF
Can-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
PremiumCompany AnnouncementsCan-Fite BioPharma Reports 2024 Financial Results and Clinical Advances
3M ago
6K
CANF
Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
Premium
The Fly
Can-Fite BioPharma reports FY24 EPS 0c vs 1c last year
3M ago
CANF
Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson
Premium
The Fly
Can-Fite BioPharma initiates Phase 3 psoriasis study of piclidenoson
3M ago
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >